Medall Spark Diagnostics Nashik Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 21-12-2024
- Paid Up Capital ₹ 2.50 Cr
as on 21-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 21.76%
(FY 2019)
- Profit -119.53%
(FY 2019)
- Ebitda -41.90%
(FY 2019)
- Net Worth -1.47%
(FY 2019)
- Total Assets -9.83%
(FY 2019)
About Medall Spark Diagnostics Nashik
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yogeshwaran Nagarajan and Ravi Aggarwal serve as directors at the Company.
- CIN/LLPIN
U74120TN2013PTC091043
- Company No.
091043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Medall Spark Diagnostics Nashik?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogeshwaran Nagarajan  | Director | 05-Dec-2022 | Current |
| Ravi Aggarwal | Director | 05-Dec-2022 | Current |
Financial Performance of Medall Spark Diagnostics Nashik.
Medall Spark Diagnostics Nashik Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 21.76% increase. The company also saw a substantial fall in profitability, with a 119.53% decrease in profit. The company's net worth dipped by a decrease of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medall Spark Diagnostics Nashik?
In 2022, Medall Spark Diagnostics Nashik had a promoter holding of 76.00% and a public holding of 24.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medall Scans And Labs Marthahalli Private LimitedActive 13 years 9 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Clumax Diagnostic And Research Centre Private LimitedActive 20 years 1 month
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Scans And Labs Ranchi Private LimitedActive 9 years 7 months
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Visakhapatnam Private LimitedActive 6 years 2 months
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medall Spark Diagnostics Nashik?
Unlock and access historical data on people associated with Medall Spark Diagnostics Nashik, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medall Spark Diagnostics Nashik, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medall Spark Diagnostics Nashik's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
